JKSE
JKSE
MEDS vs MEJA — which is the better stock?
Hetzer Medical Indonesia Tbk. (MEDS) compared against Harta Djaya Karya Tbk. (MEJA). Data through 2026-08-21.
MEDS
JKSEHetzer Medical Indonesia Tbk.
| Last close | 71 |
| 1Y return | +42.00% |
| 3Y return | -4.05% |
| 5Y return | — |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2022-08-10 |
MEJA
JKSEHarta Djaya Karya Tbk.
| Last close | 131 |
| 1Y return | +154.72% |
| 3Y return | — |
| 5Y return | — |
| P/E ratio | — coming soon |
| Dividend yield | — coming soon |
| Sector | JKSE |
| Data since | 2024-02-12 |
Shared price chart (normalized to 100)
Loading chart…
Both series are normalized to 100 at the start of the selected range so absolute price differences don't dominate the comparison.
Why compare MEDS vs MEJA?
MEDS and MEJA are both JKSE-listed stocks that often come up together when investors weigh Indonesian equity exposure. Looking at them side by side — last close, 1Y/3Y/5Y returns, and sector tag — makes it easier to pick the one that matches your portfolio's thesis. The shared chart above re-bases both tickers to 100 at the start of the range so the slope of each line directly answers "which one grew faster?".